IBDEI17C ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,19530,1,3,0)
;;=3^Ataxia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,19530,1,4,0)
;;=4^I69.193
;;^UTILITY(U,$J,358.3,19530,2)
;;=^5007455
;;^UTILITY(U,$J,358.3,19531,0)
;;=I69.293^^67^877^16
;;^UTILITY(U,$J,358.3,19531,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19531,1,3,0)
;;=3^Ataxia following other nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,19531,1,4,0)
;;=4^I69.293
;;^UTILITY(U,$J,358.3,19531,2)
;;=^5007487
;;^UTILITY(U,$J,358.3,19532,0)
;;=I69.093^^67^877^14
;;^UTILITY(U,$J,358.3,19532,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19532,1,3,0)
;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,19532,1,4,0)
;;=4^I69.093
;;^UTILITY(U,$J,358.3,19532,2)
;;=^5007423
;;^UTILITY(U,$J,358.3,19533,0)
;;=I69.893^^67^877^15
;;^UTILITY(U,$J,358.3,19533,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19533,1,3,0)
;;=3^Ataxia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,19533,1,4,0)
;;=4^I69.893
;;^UTILITY(U,$J,358.3,19533,2)
;;=^5007549
;;^UTILITY(U,$J,358.3,19534,0)
;;=I69.391^^67^877^17
;;^UTILITY(U,$J,358.3,19534,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19534,1,3,0)
;;=3^Dysphagia following cerebral infarction
;;^UTILITY(U,$J,358.3,19534,1,4,0)
;;=4^I69.391
;;^UTILITY(U,$J,358.3,19534,2)
;;=^5007516
;;^UTILITY(U,$J,358.3,19535,0)
;;=I69.191^^67^877^18
;;^UTILITY(U,$J,358.3,19535,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19535,1,3,0)
;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,19535,1,4,0)
;;=4^I69.191
;;^UTILITY(U,$J,358.3,19535,2)
;;=^5007453
;;^UTILITY(U,$J,358.3,19536,0)
;;=I69.291^^67^877^20
;;^UTILITY(U,$J,358.3,19536,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19536,1,3,0)
;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,19536,1,4,0)
;;=4^I69.291
;;^UTILITY(U,$J,358.3,19536,2)
;;=^5007485
;;^UTILITY(U,$J,358.3,19537,0)
;;=I69.091^^67^877^19
;;^UTILITY(U,$J,358.3,19537,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19537,1,3,0)
;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,19537,1,4,0)
;;=4^I69.091
;;^UTILITY(U,$J,358.3,19537,2)
;;=^5007421
;;^UTILITY(U,$J,358.3,19538,0)
;;=I69.891^^67^877^21
;;^UTILITY(U,$J,358.3,19538,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19538,1,3,0)
;;=3^Dysphagia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,19538,1,4,0)
;;=4^I69.891
;;^UTILITY(U,$J,358.3,19538,2)
;;=^5007547
;;^UTILITY(U,$J,358.3,19539,0)
;;=I69.321^^67^877^22
;;^UTILITY(U,$J,358.3,19539,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19539,1,3,0)
;;=3^Dysphasia following cerebral infarction
;;^UTILITY(U,$J,358.3,19539,1,4,0)
;;=4^I69.321
;;^UTILITY(U,$J,358.3,19539,2)
;;=^5007492
;;^UTILITY(U,$J,358.3,19540,0)
;;=I69.121^^67^877^23
;;^UTILITY(U,$J,358.3,19540,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19540,1,3,0)
;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,19540,1,4,0)
;;=4^I69.121
;;^UTILITY(U,$J,358.3,19540,2)
;;=^5007428
;;^UTILITY(U,$J,358.3,19541,0)
;;=I69.021^^67^877^24
;;^UTILITY(U,$J,358.3,19541,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19541,1,3,0)
;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,19541,1,4,0)
;;=4^I69.021
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI17C 3783 printed Apr 09, 2024@20:50:17 Page 2
IBDEI17C ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,19530,1,3,0)
+2 ;;=3^Ataxia following nontraumatic intracerebral hemorrhage
+3 ;;^UTILITY(U,$J,358.3,19530,1,4,0)
+4 ;;=4^I69.193
+5 ;;^UTILITY(U,$J,358.3,19530,2)
+6 ;;=^5007455
+7 ;;^UTILITY(U,$J,358.3,19531,0)
+8 ;;=I69.293^^67^877^16
+9 ;;^UTILITY(U,$J,358.3,19531,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,19531,1,3,0)
+12 ;;=3^Ataxia following other nontraumatic intracranial hemorrhage
+13 ;;^UTILITY(U,$J,358.3,19531,1,4,0)
+14 ;;=4^I69.293
+15 ;;^UTILITY(U,$J,358.3,19531,2)
+16 ;;=^5007487
+17 ;;^UTILITY(U,$J,358.3,19532,0)
+18 ;;=I69.093^^67^877^14
+19 ;;^UTILITY(U,$J,358.3,19532,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,19532,1,3,0)
+22 ;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
+23 ;;^UTILITY(U,$J,358.3,19532,1,4,0)
+24 ;;=4^I69.093
+25 ;;^UTILITY(U,$J,358.3,19532,2)
+26 ;;=^5007423
+27 ;;^UTILITY(U,$J,358.3,19533,0)
+28 ;;=I69.893^^67^877^15
+29 ;;^UTILITY(U,$J,358.3,19533,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,19533,1,3,0)
+32 ;;=3^Ataxia following other cerebrovascular disease
+33 ;;^UTILITY(U,$J,358.3,19533,1,4,0)
+34 ;;=4^I69.893
+35 ;;^UTILITY(U,$J,358.3,19533,2)
+36 ;;=^5007549
+37 ;;^UTILITY(U,$J,358.3,19534,0)
+38 ;;=I69.391^^67^877^17
+39 ;;^UTILITY(U,$J,358.3,19534,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,19534,1,3,0)
+42 ;;=3^Dysphagia following cerebral infarction
+43 ;;^UTILITY(U,$J,358.3,19534,1,4,0)
+44 ;;=4^I69.391
+45 ;;^UTILITY(U,$J,358.3,19534,2)
+46 ;;=^5007516
+47 ;;^UTILITY(U,$J,358.3,19535,0)
+48 ;;=I69.191^^67^877^18
+49 ;;^UTILITY(U,$J,358.3,19535,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,19535,1,3,0)
+52 ;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
+53 ;;^UTILITY(U,$J,358.3,19535,1,4,0)
+54 ;;=4^I69.191
+55 ;;^UTILITY(U,$J,358.3,19535,2)
+56 ;;=^5007453
+57 ;;^UTILITY(U,$J,358.3,19536,0)
+58 ;;=I69.291^^67^877^20
+59 ;;^UTILITY(U,$J,358.3,19536,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,19536,1,3,0)
+62 ;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
+63 ;;^UTILITY(U,$J,358.3,19536,1,4,0)
+64 ;;=4^I69.291
+65 ;;^UTILITY(U,$J,358.3,19536,2)
+66 ;;=^5007485
+67 ;;^UTILITY(U,$J,358.3,19537,0)
+68 ;;=I69.091^^67^877^19
+69 ;;^UTILITY(U,$J,358.3,19537,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,19537,1,3,0)
+72 ;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
+73 ;;^UTILITY(U,$J,358.3,19537,1,4,0)
+74 ;;=4^I69.091
+75 ;;^UTILITY(U,$J,358.3,19537,2)
+76 ;;=^5007421
+77 ;;^UTILITY(U,$J,358.3,19538,0)
+78 ;;=I69.891^^67^877^21
+79 ;;^UTILITY(U,$J,358.3,19538,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,19538,1,3,0)
+82 ;;=3^Dysphagia following other cerebrovascular disease
+83 ;;^UTILITY(U,$J,358.3,19538,1,4,0)
+84 ;;=4^I69.891
+85 ;;^UTILITY(U,$J,358.3,19538,2)
+86 ;;=^5007547
+87 ;;^UTILITY(U,$J,358.3,19539,0)
+88 ;;=I69.321^^67^877^22
+89 ;;^UTILITY(U,$J,358.3,19539,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,19539,1,3,0)
+92 ;;=3^Dysphasia following cerebral infarction
+93 ;;^UTILITY(U,$J,358.3,19539,1,4,0)
+94 ;;=4^I69.321
+95 ;;^UTILITY(U,$J,358.3,19539,2)
+96 ;;=^5007492
+97 ;;^UTILITY(U,$J,358.3,19540,0)
+98 ;;=I69.121^^67^877^23
+99 ;;^UTILITY(U,$J,358.3,19540,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,19540,1,3,0)
+102 ;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
+103 ;;^UTILITY(U,$J,358.3,19540,1,4,0)
+104 ;;=4^I69.121
+105 ;;^UTILITY(U,$J,358.3,19540,2)
+106 ;;=^5007428
+107 ;;^UTILITY(U,$J,358.3,19541,0)
+108 ;;=I69.021^^67^877^24
+109 ;;^UTILITY(U,$J,358.3,19541,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,19541,1,3,0)
+112 ;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
+113 ;;^UTILITY(U,$J,358.3,19541,1,4,0)
+114 ;;=4^I69.021
